-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0024_06-09-2008.pdf
January 01, 2008 - ,
gender), other medications, or co-morbidities for which a typical or an atypical
antipsychotic drug
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-211-rheumatoid-arthritis-disposition-comments.pdf
December 20, 2018 - Disposition of Comments for CER 211: Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review … Drug Therapy for
Early Rheumatoid Arthritis: A Systematic Review Update. … Drug Therapy for
Rheumatoid Arthritis in Adults: An Update. … This should be revised to read the correct drug. … Additionally, drug classes were not
used as part of the search string.
-
effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_june_2012.pdf
January 01, 2012 - A drug for psychotic major depression, for which the U.S. … dosages or different drug regimens. … administration and is known to
be a street drug of abuse. … Research suggests new drug targets for
depression. … Washington (DC): Drug
Enforcement Administration, U.S.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/outcomes-dental-services-rapid-research.pdf
May 01, 2025 - In addition,
drug abstinence, employment, and homelessness were assessed at First Step House only. … Drug Addiction and Periodontal Diseases. … Challenges to Studying Illicit Drug
Users. … Drug Alcohol Rev 2006,
25 (1), 27–37.
https://doi.org/10.1080/09595230500459495
. … $1 OR drug-
associated OR drug-related OR drug-seeking OR ecstasy OR MDMA OR ethanol OR EtOH OR
fentanyl
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy-surveillance.pdf
September 01, 2017 - 16 97
Anton61 2011 naltrexone,
acamprosate,
gabapentin
Medium 150 Largest for drug only 3 drug … Medium 150 Largest for drug 29 88
Naranjo69 1995 citalopram High 150 Largest for drug 64 149
Kranzler70 … Drug and alcohol dependence. 2013;133(2):440-446.
21. … Drug and alcohol dependence. 2013;133(2):754-758.
26. … The American journal of drug and alcohol abuse. 2017;43(3):324-331.
31.
-
effectivehealthcare.ahrq.gov/sites/default/files/Evidence%20Summary_1.pdf
April 01, 2020 - cognitive
impairment; biomarker accuracy for Alzheimer’s disease (AD)
in dementia; and effects of CATD drug … Few trials directly compared
different drug treatments. … Future
BPSD trials also should directly compare drug
and nondrug treatment strategies, and drug trials … Food & Drug Administration. U.S. … Food & Drug Administration.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-1-year-final-report-updated-title_0.pdf
May 01, 2024 - Computerized Clinical Decision Support To Prevent Medication Errors and Adverse Drug
Events ........ … Reducing Adverse Drug Events Related to Anticoagulant
Use in Adults
9a. … involving
CDSS to reduce medication errors and adverse drug
events. … Computerized Clinical Decision Support To Prevent Medication Errors and Adverse Drug Events
1a. … Reducing Adverse Drug Events Related to Anticoagulant Use in Adults
9a.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_disposition-comments.pdf
May 13, 2014 - J
Stud Alc Drug Dependence. 2012;73 (6):991-997
Thank you for the comment. … longitudinal care coordinated by a primary
care clinician with no CCM for people with alcohol or
drug … As I said before, if they
take the drug at the right dose, it is unlikely that drinking will occur. … J Stud Alc Drug Dependence. 2012;73 (6):991-997.
5. Dunbar JL, Tumcliff RZ, Dong Q, et al. … Only if a trial recruited more patients that responded to drug A
than drug B would you get a difference
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1506.pdf
June 01, 2015 - similar drugs in the same class are read separately), and then topics in the same class of a
device, drug … preliminary phase III data for drugs (or
preliminary late-phase clinical trial data for off-label drug … Food and Drug Administration has not approved an AD-treating drug since
galantamine in 2004. … We continue
to monitor early developments of new drug candidates and diagnostics in this priority area … This drug, in
various formulations, is approved and widely used to manage diabetes indications; no major
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-2.pdf
June 01, 2022 - Reviews, PsycINFO®, and Scopus from September 2, 2021 to December 30, 2021.We also
searched Food and Drug … Placebo
From the previous report,
NSAIDs as a drug class,
compared with placebo,
resolved pain at … No change in SOE
supporting the
effect of NSAIDs as
a drug class vs. … analyses
Abbreviations: KQ = Key Question; mg = milligram; NSAID = nonsteroidal anti-inflammatory drug … Therapy]
24 exp Vomiting/dt [Drug Therapy]
25 (((drug* or agent* or medication*) adj3 (nausea or
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced-topic-refinement.pdf
November 01, 2022 - Framework for FDA's Real-World Evidence Program US Food & Drug Administration. … and Biological Products US Food & Drug Administration. … Guidance for Industry US Food & Drug Administration. … and Biological Products US Food & Drug Administration. … Data Standards for Drug and Biological Product Submissions Containing Real-World Data US
Food & Drug
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-reporting-bias_methods.pdf
November 01, 2013 - Food and Drug Administration. … Drug Approval Process
Manufacturers are required to submit a New Drug Application to the FDA for all … The Drugs@FDA site may be searched by the generic or trade drug name (not drug class) for
Statistical … Reporting bias in
drug trials submitted to the Food and Drug
Administration: review of publication … Drug Effectiveness Review Project.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
January 01, 2015 - Food and Drug Administration (FDA) status of products subject to FDA regulation at the time
the cost … health benefit a drug provides for a
specific indication. … Whether these initiatives will alter drug
pricing is unclear at this time, although Dr. … million to
$180 million per year in costs of this new drug for the labeled indication. … Food and Drug
Administration (FDA).
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine-update_research-protocol.pdf
May 15, 2017 - Published online: May 15, 2017
Evidence-based Practice Center Systematic Review Protocol
Project Title: Drug … However, data on disease-modifying antirheumatic drug (DMARD)
use in the first 3 months are limited. … Food and Drug
Administration; RA = rheumatoid arthritis; TNF = tumor necrosis factor; ts = targeted … Choosing a
RA treatment drug can be difficult with these populations. … Drug Therapy for Rheumatoid Arthritis in
Adults: An Update [Internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_executive.pdf
July 01, 2014 - A vs. drug B)? … Using a second drug to augment the effects of the
primary drug and comparing this treatment with
monotherapy … with a single drug
ii. … A
vs. drug B)? … Using a second drug to augment the effects of the
primary drug and comparing this treatment with
monotherapy
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-pregnancy-postpartum_research-protocol.pdf
March 29, 2013 - A vs. drug B)? … Using a second drug to augment the effects of the primary drug and comparing
this treatment with monotherapy … with a single drug
ii. … A vs. drug B)? … The
combination include:
(a) Using a second drug to augment the effects of the primary drug and
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/mat-retention-strategies-rapid-review-1.pdf
August 01, 2020 - drug users: a
randomized controlled trial. … Drug
and alcohol dependence. 2015;147:122-9. … Drug and
opioid-involved overdose deaths—United
States, 2013–2017. … Int J Drug Policy. 2018;56:73-80.
doi:
https://dx.doi.org/10.1016/j.drugpo.2018.03.
012. … drug users: a
randomized controlled trial.
-
effectivehealthcare.ahrq.gov/products/arthritis-psoriatric/research
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-mortality-elderly_research.pdf
March 01, 2009 - and more likely to exclude those who
discontinued the drug due to drug intolerance, or treatment failure … http://www.fda.gov/cder/drug/advisory/antipsychotics.htm
http://www.fda.gov/cder/drug/advisory/antipsychotics.htm … Drug Saf 2007;30(1):47-57.
35. Wehmeier PM, Heiser P, Remschmidt H. … Adverse Drug React Toxicol Rev
2002;21(4):189-203.
38. Fox CS, Evans JC, Larson MG, et al. … Antipsychotic drug use and mortality in older
adults with dementia.
-
effectivehealthcare.ahrq.gov/sites/default/files/kravitz_eccs2012.pdf
January 01, 2012 - Food and Drug Administration opened the door in 1997 by
reinterpreting own rules. … (clinical) approaches
Slide 18: Policy
Approaches
• Improve the quality of the prescription drug … Slide 19: What Is
Being
Done
• Drug facts
box
o Presents evidence about the benefits and